DZ3282A1 - Traitement du psoriasis - Google Patents

Traitement du psoriasis

Info

Publication number
DZ3282A1
DZ3282A1 DZ013282A DZ013282A DZ3282A1 DZ 3282 A1 DZ3282 A1 DZ 3282A1 DZ 013282 A DZ013282 A DZ 013282A DZ 013282 A DZ013282 A DZ 013282A DZ 3282 A1 DZ3282 A1 DZ 3282A1
Authority
DZ
Algeria
Prior art keywords
psoriasis
treatment
Prior art date
Application number
DZ013282A
Other languages
English (en)
Inventor
Holly Read Thomasson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ3282A1 publication Critical patent/DZ3282A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DZ013282A 2000-03-07 2001-02-20 Traitement du psoriasis DZ3282A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18750800P 2000-03-07 2000-03-07
PCT/US2001/005260 WO2001066101A2 (fr) 2000-03-07 2001-02-20 Traitement du psoriasis

Publications (1)

Publication Number Publication Date
DZ3282A1 true DZ3282A1 (fr) 2001-09-13

Family

ID=22689272

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013282A DZ3282A1 (fr) 2000-03-07 2001-02-20 Traitement du psoriasis

Country Status (19)

Country Link
US (1) US6683114B2 (fr)
EP (1) EP1267859A2 (fr)
JP (1) JP2003525899A (fr)
KR (1) KR20020081403A (fr)
CN (1) CN1407890A (fr)
AU (1) AU4529101A (fr)
BR (1) BR0108980A (fr)
CA (1) CA2400571A1 (fr)
DZ (1) DZ3282A1 (fr)
EA (1) EA200200948A1 (fr)
HR (1) HRP20020729A2 (fr)
HU (1) HUP0204551A2 (fr)
IL (1) IL150479A0 (fr)
MX (1) MXPA02008659A (fr)
NO (1) NO20024236D0 (fr)
PL (1) PL357042A1 (fr)
SK (1) SK12812002A3 (fr)
WO (1) WO2001066101A2 (fr)
ZA (1) ZA200205266B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
CN2559015Y (zh) * 2002-04-29 2003-07-02 谢基生 电动式双层近红外滤光型防盗摄影监控装置
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004075902A1 (fr) * 2003-02-28 2004-09-10 Amedis Pharmaceuticals Ltd. Utilisation de derives de silicium de venlafaxine permettant de traiter ou de prevenir le psoriasis ou un trouble panique
WO2005011583A2 (fr) * 2003-07-28 2005-02-10 Leslie Joe Dunaway Traitement de la rhinite allergique et de l'asthme
WO2007146796A2 (fr) * 2006-06-13 2007-12-21 Ramot At Tel-Aviv University Ltd. Composés antiprolifératifs, compositions contenant ceux-ci et procédés d'utilisation de ceux-ci
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
US9326935B2 (en) * 2013-11-08 2016-05-03 Eli Lilly And Company Atomoxetine solution

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183323B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for producing 17,18-dihydro-apovincaminol-3-comma down comma aaove-4-comma down comma above-5-comma down comma aaove-trimethoxy-benzoate and acid additional salts thereof
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
EP1069900B1 (fr) * 1998-04-09 2005-08-10 Pharmacia & Upjohn Company LLC Nouveaux traitements avec "reboxetine" pour troubles nerveux
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6403645B2 (en) * 2000-03-16 2002-06-11 President And Fellows Of Harvard College Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them

Also Published As

Publication number Publication date
WO2001066101A2 (fr) 2001-09-13
MXPA02008659A (es) 2003-02-24
WO2001066101A3 (fr) 2002-02-07
NO20024236L (no) 2002-09-05
HRP20020729A2 (en) 2004-02-29
EA200200948A1 (ru) 2003-02-27
SK12812002A3 (sk) 2003-08-05
US20030045585A1 (en) 2003-03-06
BR0108980A (pt) 2003-06-03
HUP0204551A2 (hu) 2003-06-28
JP2003525899A (ja) 2003-09-02
CA2400571A1 (fr) 2001-09-13
AU4529101A (en) 2001-09-17
PL357042A1 (en) 2004-07-12
US6683114B2 (en) 2004-01-27
ZA200205266B (en) 2003-10-01
EP1267859A2 (fr) 2003-01-02
CN1407890A (zh) 2003-04-02
NO20024236D0 (no) 2002-09-05
IL150479A0 (en) 2002-12-01
KR20020081403A (ko) 2002-10-26

Similar Documents

Publication Publication Date Title
EE200200461A (et) Pteridiiniühendid psoriaasi raviks
MA25519A1 (fr) Traitement de matieres minerales
FIU20060389U0 (fi) Luusairauksien hoito
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20024273D0 (no) Terapeutiske anvendelser av PPAR-mediatorer
NO20026008L (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
DZ3282A1 (fr) Traitement du psoriasis
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
NO20030978L (no) Behandling av urindysfunksjon
DE60103685D1 (de) Behandlung von Poriomania
NO20032156D0 (no) Behandling av angstforstyrrelser
EE200200415A (et) FSH kasutamine viljatuse raviks
DE60122601D1 (de) Behandlung von entzündlichen Darmerkrankungen
DE60133596D1 (de) S-Methyl-Dihydro-Ziprasidone für die Behandlung von Schizophrenie
DE60125035D1 (de) Behandlung von plasmid-haltigen lösungen
ITMI20011820A0 (it) Trattamento di ustioni
DE60103071D1 (de) Behandlung von flüssigkeiten
FR2825893B3 (fr) Tunnel de traitement
NO20030762D0 (no) Forbedret spesifisitet i behandling av sykdommer
FR2825918B1 (fr) Procede cosmetique du traitement des vergetures
NO20011136L (no) Fremgangsmåte ved byggbehandling
SE0104249D0 (sv) Method of treatment
FI20001419A0 (fi) Järjestely viiraveden käsittelyssä